Hikal informs about unaudited financial results

24 Oct 2018 Evaluate

Hikal has informed that the meeting of the Board of Directors of the Company is scheduled on 01/11/2018, to consider and approve unaudited financial results for quarter ended 30th September 2018.

The above information is a part of company’s filings submitted to BSE.

Hikal Share Price

390.75 3.10 (0.80%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.